Ondansetron
Product Images NDC 50436-0134

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 50436-0134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360134)

Ondansetron 4 mg orally disintegrating tablets packaging label showing a blister pack containing 30 tablets in total (3 blisters each with 10 tablets). The label includes the drug name, strength, formulation, manufacturer Glenmark Pharmaceuticals Ltd. in India, and Unit Dose Services as the labeler. It specifies storage conditions (20-25°C) and contains warnings and control information.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework including benzene and heterocyclic rings, along with a ketone group and methyl-substituted nitrogen atoms.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate showing its molecular arrangement with bonds and atoms including methyl groups, rings, and ketone functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.